Taiwan FDA registration 6f9b317881954234facd1e9ad1f341bf
"Broadcom" insulin syringe (with needle)
TW: "博通" 胰島素注射器(附針)
Taiwan·Risk Class 2·PROMISEMED HANGZHOU MEDITECH CO., LTD.·Registered Aug 04, 2024 – Aug 04, 2029ActiveRegistration details
- Analysis ID
- 6f9b317881954234facd1e9ad1f341bf
- Customs Code
- DHA09200158901
Company information
- Manufacturer
- PROMISEMED HANGZHOU MEDITECH CO., LTD.
- Manufacturer Country
- China
- Authorized Representative
- BROADMASTER BIOTECH. CORP.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5570 皮下單腔針;; J.5860 活塞式注射筒
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Aug 04, 2024
- Expiry Date
- Aug 04, 2029
About this record
Access comprehensive regulatory information for "Broadcom" insulin syringe (with needle) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6f9b317881954234facd1e9ad1f341bf and manufactured by PROMISEMED HANGZHOU MEDITECH CO., LTD.. The authorized representative in Taiwan is BROADMASTER BIOTECH. CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices